Skip to main content

Table 1 Patient characteristics

From: Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma

Variable No. of patients (%)
No. of patients 230 (100)
Age: Median [range], y 49 [13–78]
Gender  
  Female 26 (11.3)
  Male 204 (88.7)
HBsAg  
  Negative 15 (6.5)
  Positive 215 (93.5)
AFP: Median [range], ng/mL 157.3 [0.6-121000]
GGT: Median [range], U/l 45.0 [3.5-655.5]
Tumor size: Median [range], cm 4.6 [1.0-18.0]
Liver cirrhosis  
  No 50 (21.7)
  Yes 180 (78.3)
Child-Pugh class  
  A 225 (97.8)
  B 5 (2.2)
Tumor number  
  Single 213 (92.6)
  Multiple 17 (7.4)
Satellite nodule  
  No 199 (86.5)
  Yes 31 (13.5)
Tumor capsule  
  No/incomplete 141 (61.3)
  Complete 89 (38.7)
Tumor differentiation  
  I 14 (6.1)
  II 143 (62.2)
  III 66 (28.7)
  IV 7 (3.0)
Vascular invasion  
  No 207 (90.0)
  Yes 23 (10.0)
TNM stage  
  I 178 (77.4)
  II 11 (4.8)
  III 41 (17.8)
BCLC stage  
  0 20 (8.7)
  A 106 (46.1)
  B 80 (34.8)
  C 24 (10.4)
Recurrence status  
  No 105 (45.6)
  Early recurrence 85 (37.0)
  Late recurrence 40 (17.4)